Smart science to improve lives™
Pharma
  • Login | Register
Pharma

Immunostimulators

Priming the immune system through the use of tailored immunostimulators is an important component of vaccine development. Discover what selection works best for you.

Speak with an expert

Prime effective immune responses

Elicit an amplified immune response through specific antigen presentation

Immunostimulators directly influence the immune response. Your selection of immunostimulators will direct the type of immune response. For example, whether the resultant response will be Th1, Th2, Th17 or T-cell mediated immunity.

As a result, they can play important roles in vaccine development by defining the type of immunity obtained (the immune fingerprint.)

Explore our range of immunostimulators to fulfil your vaccine's immune correlates of protection.

Download our exclusive vaccines brochure

Toll-like receptor (TLR) agonists are a class of proteins that play fundamental roles in innate immunity. Their discovery was honoured with the 2011 Nobel Prize. By mimicking the structure of pathogens, they can help stimulate the immune system. They are known as excellent adjuvant targets, having been part of several approved vaccines, such as for cervical cancer, shingles and Hepatitis B.

TLR agonists

Toll-like receptor (TLR) agonists are a class of proteins that play fundamental roles in innate immunity. Their discovery was honoured with the 2011 Nobel Prize. By mimicking the structure of pathogens, they can help stimulate the immune system. They are known as excellent adjuvant targets, having been part of several approved vaccines, such as for cervical cancer, shingles and Hepatitis B.

Looking for a product?

Find a product now >
Derived from the bark of Quillaja saponaria Molina, these natural glycosides can act as potent adjuvants. Their unique ability to stimulate Th1 immune responses and the production of cytotoxic T-cells makes them valuable vaccine adjuvant candidates for both human and veterinary purposes.

Saponins

Derived from the bark of Quillaja saponaria Molina, these natural glycosides can act as potent adjuvants. Their unique ability to stimulate Th1 immune responses and the production of cytotoxic T-cells makes them valuable vaccine adjuvant candidates for both human and veterinary purposes.
  • QS 21

    QS 21

    *sample can be ordered for investigational use only* A powerful immunostimulatory saponin that acts as a potent vaccine adjuvant, QS 21 can stimulate both cell-mediated (Th1) and humoral (Th2) immune...

    Add product to favourites View product
  • Quil-A

    Quil-A™

    A versatile immunostimulatory saponin that’s widely used as a potent veterinary adjuvant, Quil-A can work against both intra- and extra-cellular pathogens, stimulating innate and Th-mediated adaptive immune...

    Add product to favourites View product

Looking for a product?

Find a product now >
Our aseptic process ensures we can deliver sterile aluminium according to GMP EudraLex Volume 4. We are one of the only companies worldwide to operate at such premium standards. Our Quality Management System is continually improved through established metrics.

Exceptional standards in adjuvant manufacturing

Our aseptic process ensures we can deliver sterile aluminium according to GMP EudraLex Volume 4. We are one of the only companies worldwide to operate at such premium standards. Our Quality Management System is continually improved through established metrics.
As a key player in adjuvant development since 1939, our adjuvants have consistently been featured in countless peer-reviewed papers. Our leading R&D capabilities demonstrate our determination to advance drug delivery systems and novel vaccine adjuvants to tackle even more pathogens.

A history of supporting vaccines

As a key player in adjuvant development since 1939, our adjuvants have consistently been featured in countless peer-reviewed papers. Our leading R&D capabilities demonstrate our determination to advance drug delivery systems and novel vaccine adjuvants to tackle even more pathogens.
Developing and manufacturing vaccines is a costly challenge. Our team of experts are committed to helping you choose the right adjuvant for your needs. Save time and money by leveraging our decades worth of experience.

Dedicated to your vaccine success

Developing and manufacturing vaccines is a costly challenge. Our team of experts are committed to helping you choose the right adjuvant for your needs. Save time and money by leveraging our decades worth of experience.

Download our adjuvants brochure here:

Addressing the challenges of vaccine formulation

indicates required field
Please provide your first name
Please provide your last name
E-mail is not valid
We need your consent
Please complete the recaptcha and resubmit the form.

Supporting Literature

Enter your contact details to receive supporting materials.
Addressing the challenges of vaccine formulation brochure by Croda Pharma

Addressing the challenges of vaccine formulation

Adjuvant systems

Adjuvant Systems

Your partner for modern vaccine development. Our unique GMP portfolio and outstanding expertise can meet your adjuvant needs. Collaborate with our scientists to create the vaccines of tomorrow.

Take me there

Vaccine delivery systems

What you add to a vaccine can make it more potent. Our selection of aluminium-based and liposomal adjuvants, such as our newly available CAF range, can help improve the effectiveness of your vaccine formulations.

Learn more

Contact our experts today

Croda Pharma is a world leader in pharmaceutical excipients, vaccine adjuvants and innovative lipids for human and veterinary applications. Get in touch with our experts today to get your next project started.
Please provide an enquiry type
Please provide your first name
Please provide your last name
Please provide your company name
Please provide an email address
Please provide your message
Please complete the recaptcha and resubmit the form.
Form is invalid, please check again!
Thank you for getting in touch. One of experts will be in contact soon.